R.; New technology for noninvasive evaluation of coronary artery disease. Circulation. 115 2007:1464-1480.
A.N.; The growth of diagnostic imaging services. J Am Coll Cardiol. 45 2005:2093-2094.
D.E.; Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993–2001. Circulation. 113 2006:374-379.
U.S. Government Accountability Office
Medicare Part B Imaging Services: Rapid Spending Growth and Shift to Physician Offices Indicate Need for CMS to Consider Additional Management Practices. Accessed August 16, 2008. http://www/gao.gov/news.items/d08452.pdf
R.B.; The association between local diagnostic testing intensity and invasive cardiac procedures. JAMA. 275 1996:1161-1164.
P.S.; Defining optimal research study design for cardiovascular imaging using computed tomography angiography as a model. Am J Cardiol. 102 2008:943-948.
R.F.; Computed tomographic angiography: more than just a pretty picture?. J Am Coll Cardiol. 49 2007:1827-1829.
S.; Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 298 2007:317-323.
E.J.; Computed tomography—an increasing source of radiation exposure. N Engl J Med. 357 2007:2277-2284.
V.M.; Turf wars in radiology: updated evidence on the relationship between self-referral and the overutilization of imaging. J Am Coll Radiol. 5 2008:806-810.
T.A.; Direct-to-consumer marketing of high-technology screening tests. N Engl J Med. 346 2002:529-531.
M.T.; Cost-effectiveness analysis in the assessment of diagnostic imaging technologies. Radiology. 235 2005:361-370.
J.E.; The price for probability: comparing the costs of diagnostic testing strategies. J Nucl Cardiol. 14 2007:142-144.
J.R.; The efficacy of diagnostic imaging. Med Decis Making. 11 1991:88-94.
H.M.; Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging. J Am Coll Cardiol. 48 2006:2141-2151.
P.S.; Improving imaging: our professional imperative. J Am Coll Cardiol. 2006:2152-2153.
L.E.; Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 359 2002:909-919.
E.; Medicine. A bruising battle over lung scans. Science. 320 2008:600-603.
G.; Screening for lung cancer. N Engl J Med. 343 2000:1627-1633.
F.; Neuroblastoma screening at one year of age. N Engl J Med. 346 2002:1047-1053.
R.J.; When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?. Ann Intern Med. 144 2006:850-855.
H.J.; No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol. 37 2001:81-88.
The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN [TCT00282711]. Accessed August 24, 2008. www.clinicaltrials.gov
E.R.; Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation. 118 2008:1294-1303.
E.L., Th Wackers
F.J.; An economic analysis of an aggressive diagnostic strategy with single photon emission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chest pain but nondiagnostic electrocardiograms: results from a randomized trial. Ann Emerg Med. 35 2000:17-25.
D.S.; Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA. 288 2002:2693-2700.
J.M.; The evaluation of the worth of early disease detection. J R Coll Gen Pract. 16
Multicentre Aneurysm Screening Study Group The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 360 2002:1531-1539.
D.; Routine ultrasound screening in management of abdominal aortic aneurysms. Br Med J. 296 1988:1709-1710.
H.; Randomized clinical trial of screening for abdominal aortic aneurysm in women. Br J Surg. 89 2002:283-285.
E.J.; Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 115 2007:1481-1501.
G.; The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review. Health Technol Assess. 10 2006:iii-iv. ix–x, 1–41.
D.; Defining a rational approach to screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol. 52 2008:330-332.
D.A.; Time to foster a rational approach to preventing cardiovascular morbid events. J Am Coll Cardiol. 52 2008:327-329.
H.S.; From vulnerable plaque to vulnerable patient part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 98 2006:2H-15H.
B.H.;American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). J Am Coll Cardiol. 49 2007:378-402.
J.J.; Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 358 2008:1336-1345.
R.S.; Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 114 2006:1761-1791.
R.T.;American Society of Echocardiography Carotid Intima-Media Thickness Task Force Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 21 2008:93-111.
R.C.; Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 168 2008:1333-1339.
M.S.; Screening for coronary heart disease: has the time for universal imaging arrived?. Cleve Clin J Med. 74 2007:645-656.
N.J.; Screening: a step too far. A matter of concern. J Med Screen. 14 2007:163-164.
B.H.;American College of Cardiology ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiolg. 42 2003:1318-1333.
W.F.; ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. J Am Coll Cardiol. 29 1997:862-879.
H.; Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 93 1996:905-914.
D.S.; Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation. 100 1999:2140-2145.
F.A.; Risk stratification using stress echocardiography: incremental prognostic value over historic, clinical, and stress electrocardiographic variables across a wide spectrum of Bayesian pretest probabilities for coronary artery disease. J Am Soc Echocardiogr. 20 2007:244-252.
R.; Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 342 2000:1163-1170.
A.B.; The role of cardiac risk factor burden in diagnosing acute coronary syndromes in the emergency department setting. Ann Emerg Med. 49 2007:145-152. 152 e1.
P.J.; The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 284 2000:835-842.
W.J.; Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 283 2000:3223-3229.
E.S.; Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes. Ann Emerg Med. 35 2000:213-220.
P.P.; Does having a chest pain center impact the treatment and survival of acute myocardial infarction patients (abstr)?. Circulation. 110 2004:III409
J.A.; Prospective multicenter study of quantitative pretest probability assessment to exclude acute coronary syndrome for patients evaluated in emergency department chest pain units. Ann Emerg Med. 47 2006:447
Y.; Triage of patients with chest pain in the emergency department: a comparative study of physicians' decisions. Am J Med. 112 2002:95-103.
G.C.; Medicolegal aspects of acute myocardial infarction. Emerg Med Clin North Am. 19 2001:511-521.
M.A.; Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial. Med Care. 33 1995:598-610.
M.A.; Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) study. Am J Cardiol. 80 1997:563-568.
M.; Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Circulation. 118 2008:586-606.
R.O.; Identification of viable myocardium. Circulation. 94 1996:2674-2680.
S.H.; Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 32 2007:375-410.
O.E.; Stunning, hibernation, and assessment of myocardial viability. Circulation. 117 2008:103-114.
J.E.; Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 39 2002:1151-1158.
C.M.;STICH Investigators The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg. 134 2007:1540-1547.
V.T.; Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 111 2005:295-301.
A.J.; Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 103 2001:1759-1764.
E.; Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation. 112 2005:745-758.
T.M.; Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 45 2005:381-387.
R.O.; Mitral regurgitation in chronic heart failure: more questions than answers?. Curr Cardiol Rep. 6 2004:96-99.